Ranier's Compounding Laboratory recalls PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 1
Recalled August 22, 2018 · FDA recall D-1092-2018 · Ranier's Compounding Laboratory
Hazard
Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile. · FDA Class II
Units
1 vial
Sold at
Product was distributed within the state of Pennsylvania.
Description
Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.
Product
PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
Manufacturer(s)
Ranier's Compounding Laboratory
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →